Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape - GBI Research Reports

Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape

Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape - GBI Research Reports
Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape
Published Oct 15, 2011
91 pages — Published Oct 15, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Researchs report, Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape provides detailed insight into the American API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints, and competitive landscape of major producers in the region. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and SWOT analysis of the API markets in the major countries of the region. Overall, the report presents a comprehensive analysis of the American API market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

The API Market revenues in the Americas are expected to grow at a Compounded Annual Growth Rate (CAGR) of 4.7% from 2010 to 2015. As the North American pharmaceutical market recovers from the impacts of economic downturn, the API market revenues are expected to witness a steady growth. The faster growing markets of South and Central America will have greater contribution to the overall Americas API market growth. Brazil, especially, is witnessing very strong growth in pharmaceuticals and API market revenues and is expected to overtake Mexico in the coming years.

Scope

- Market revenue data for APIs from 2005 to 2010 and forecast for six years to 2016
- API markets in key countries in the region: the US, Canada, Mexico and Brazil
- API industry structure and market trends such as shift of market from branded to generic and rise of biotechnology in the American region
- Drivers of the API market, such as the growth of generic drugs, and restraints, such as patent expiries and SWOT analysis of the API market for the regions key countries
- Information on the competitive landscape, with shares of leading companies such as Pfizer Inc., Astrazeneca International, GlaxoSmithKline Pharmaceuticals Ltd., Roche and Sanofi Aventis
- Analysis of API revenue based on product types in the American market and in key countries of the region.
- Analysis of API revenue based on therapeutic categories in the key countries.

Reasons to buy

- Develop business strategies with the help of specific insights on the American API market.
- Identify opportunities and challenges in the American API market.
- Invest in the growing segments of the API market.
- Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the American API market.
- Benchmark your operations and strategies against the major players in the global API market.

  
Source:
Document ID
GBICH0053MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents46
  List of Tables71
  List of Figures82
Introduction101
  GBI Report Coverage101
Americas API Market1133
  Americas API Industry Structure111
  Americas API Industry Challenges121
    Economic Downturn has Restricted Investment in Pharmaceutical Industry121
    High Costs Hinder New Drug Development in the Region121
    Maturity of Synthetic APIs Hamper Profit Margin Growth121
    Regulatory Changes Lead to Delays in the Launch of New Drugs in the Market121
    Patent Expiries of Best Selling Drugs Threatens Revenue Growth121
  Americas API Industry Trends121
    Patent Expiries are Changing Pharmaceutical Market Dynamics in America121
    Specialty Driven Products are Expected to Play an Important Role in the American API Market121
    Outsourcing of API Manufacturing is Growing Fast in America131
    Mergers and Acquisitions (M&A) Activities have Increased Significantly in the American Pharmaceutical Industry131
  Americas API Market Revenue Analysis and Forecasts to 2016142
  Americas API Market Revenue Share Analysis by Product Type and Forecasts to 2016161
    Americas API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecast to 2016171
    Americas API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecast to 2016181
  Americas API Market Revenue Share Analysis by Country and Forecasts to 2016191
  North America API Market201
    North America API Market Overview201
    North America API Market Drivers201
      Continuous Growth in the Pharmaceutical Industry Sustains the API Market s Growth in North America201
      Generic Sector Spurs the Growth of the API Market of the Region201
      Increasing Focus on Biological Drugs Helps the API Market s Revenue Growth201
    North America API Market Restraints201
      Recent Economic Slowdown has Restricted the Growth of the Pharmaceutical Industry201
      High Cost Involved in New Drug Development Hampers Innovation201
      Patent Expiries of Blockbuster Molecules will Contain the Growth of the API Market in North America211
    North America API Market Revenue Analysis and Forecasts to 2016222
    North America API Market Revenue Share Analysis by Product Type and Forecasts to 2016241
      North America API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecast to 2016243
      North America API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecast to 2016273
    North America API Market Revenue Share Analysis by Country and Forecasts to 2016301
  North America API Market Competitive Landscape312
  South and Central America API Market331
    South and Central America API Market Overview331
    South and Central America API Market Drivers331
      Growing Demand for Pharmaceuticals in the Region is the Major Force Behind API Market Growth331
      Improvement in Regulatory Environment331
      Government Support and Growing Investments in the Pharmaceutical Industry Gives a Boost to API Market Growth331
      Increasing Number of Clinical Trials Leading to Market Growth331
      Ageing Population and Increasing Prevalence of Lifestyle Diseases Fuel Market Growth331
    South and Central America API Market Restraints341
      Import Dependence for API Restricts Market Growth341
      Delay in Regulatory Processes Hinders the Industry Growth341
    South and Central America API Market Revenue Analysis and Forecasts to 2016342
    South and Central America API Market Revenue Share Analysis by Product Type and Forecasts to 2016361
      South and Central America API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecast to 2016363
      South and Central America API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecast to 2016393
    South and Central America API Market Revenue Share Analysis by Country and Forecasts to 2016421
    South and Central America API Market Competitive Landscape431
The US API Market4412
  The US API Market Overview441
  The US API Market Drivers441
    The Rising Incidence of Lifestyle and Old Age Diseases is Giving Rise to API Demand in the Region441
    Growth in Oncology is One of the Major Contributing Factors to the Growth of APIs in the Region441
    Growth in Biotechnology will Favor Growth of API Market Revenues441
    Increasing Focus on High Potency APIs Helps Market Growth441
  The US API Market Restraints441
    The Economic Downturn has Restricted the Growth of API Demand in the US441
    Decreasing Focus on the Innovator Sector Limits the Growth of the US API Market451
    Patent Expiry of Some Blockbuster Molecules Will Adversely Affect the Growth of the API Market in the Region451
    Rising Competition from China and India is Creating Price Pressure in the US Market451
  The US API Market Revenue Analysis and Forecasts to 2016452
  The US API Market Revenue Share Analysis by Product Type and Forecasts to 2016471
    The US API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2016473
    The US API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2016503
  The US API Market Revenue Share Analysis by Therapeutic Category531
  The US API Market SWOT Analysis541
    Strengths541
      World s Largest Pharmaceutical Market541
      Increased Focus on Innovation541
    Weaknesses541
      Maturity of the Market541
      Large Number of Patent Expiries541
    Opportunities551
      Growing Market for Generics551
      Growth in Biotechnology551
      Increased Coverage of Insurance551
    Threats551
      Increasing Competition from Generics551
      Rising R&D Costs551
      Tighter Regulations551
Canada API Market5611
  Canada API Market Overview561
  Canada API Market Drivers561
    Government Support for Increasing Healthcare Standards Encourages API Market Growth561
    Fast Growing Biotechnology Industry in the Country Increases Demand for APIs561
    Growth in Old Age Population in Canada Provides Leads to Growth of the API Market561
  Canada API Market Restraints561
    Patent Expiries of Some Blockbuster Drugs Will Negatively Impact the API Market561
    Price Controls by the Government Affects API Market Revenues561
  Canada API Market Revenue Analysis and Forecasts to 2016571
  Canada API Market Revenue Share Analysis by Product Type and Forecasts to 2016581
    Canada API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2016583
    Canada API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2016613
  Canada API Market Revenue Share Analysis by Therapeutic Category641
  Canada API Market SWOT Analysis651
    Strengths651
      Government Support651
      Large Biotechnology Industry651
    Weaknesses651
      Large Number of Drug Patent Expiries651
      Government Drug Price Controls651
    Opportunities661
      Ageing Population661
      Increasing Demand for Generic Drugs661
      Growing Export Market661
    Threats661
      Drug Price Decline661
Mexico API Market6711
  Mexico API Market Overview671
  Mexico API Market Drivers671
    Strong Growth in Pharmaceutical Market Leads the API Market in Mexico671
    Rapid Growth in Generics Market Encouraging API Demand671
  Mexico API Market Restraints671
    Patent Expiries of Blockbuster Drugs will Negatively Impact Market Revenue Growth671
    The Problem of Counterfeits Challenging the Market671
  Mexico API Market Revenue Analysis and Forecasts to 2016681
  Mexico API Market Revenue Share Analysis by Product Type and Forecasts to 2016691
    Mexico API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2016693
    Mexico API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2016723
  Mexico API Market Revenue Share Analysis by Therapeutic Category751
  Mexico API Market SWOT Analysis761
    Strengths761
      Pharmaceutical Market Growth761
      Relatively Stronger Patent Protection761
    Weaknesses761
      Patent Expiries761
      Counterfeits771
    Opportunities771
      Fast Growing Generic Drugs Market771
    Threats771
      Restrictions on Healthcare Expenditure771
Brazil API Market7811
  Brazil API Market Overview781
  Brazil API Market Drivers781
    Strongly Growing Economy Gives Boost to the API Market781
    Increase in Old Age Population Gives Rise to APIs Demand781
    Rapidly Growing Demand for Generic Drugs will Drive the Country s API Market781
  Brazil API Market Restraints781
    Delay in Drug Approvals Hinders the Market Growth781
    The Dependency on Imports for Pharmaceutical Raw Materials Restricts Market Growth781
  Brazil API Market Revenue Analysis and Forecasts to 2016791
  Brazil API Market Revenue Share Analysis by Product Type and Forecasts to 2016801
    Brazil API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2016803
    Brazil API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2016833
  Brazil API Market Revenue Share Analysis by Therapeutic Category861
  Brazil API Market SWOT Analysis871
    Strengths871
      Strong Economic Growth871
      Large Generics Market871
      Government Support to Healthcare Investments871
    Weaknesses881
      Limited Infrastructure and Technical Capabilities881
      Reliance on Imports881
      Weaker IP Protection System881
    Opportunities881
      Rapid Growth in Healthcare Industry881
      Ageing Population881
    Threats881
      Government Support Favoring Public Sector881
      Price Fluctuations881
Appendix893
  Abbreviations891
  Methodology892
    Coverage891
    Secondary Research901
    Primary Research901
    Expert Panel Validation901
  Contact Us901
  About GBI Research911
  Disclaimer911

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape" Oct 15, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Active-Pharmaceutical-Ingredients-APIs-in-the-Americas-Market-to-2016-Growth-in-Biotechnology-and-Generic-Segments-and-the-Pharmaceutical-Patent-Cliff-will-Shape-the-Landscape-2115-281>
  
APA:
GBI Research Reports. (2011). Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape Oct 15, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Active-Pharmaceutical-Ingredients-APIs-in-the-Americas-Market-to-2016-Growth-in-Biotechnology-and-Generic-Segments-and-the-Pharmaceutical-Patent-Cliff-will-Shape-the-Landscape-2115-281>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.